Article
Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells
7 Jun 2014
Abstract excerpt
Glioblastoma is the most prevalent primary brain tumor and is essentially universally fatal within 2 years of diagnosis. Glioblastomas contain cellular hierarchies with self-renewing glioblastoma stem cells (GSCs) that are often resistant to chemotherapy and radiation therapy. GSCs express high amounts of repressor element 1 silencing transcription factor (REST), which may contribute to their resistance to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
